Alzheimer's disease and miRNA effects (WP2059)

Homo sapiens

Authors

Nathan Salomonis , Thomas Kelder , Kristina Hanspers , Alex Pico , Jonathan Mélius , Egon Willighagen , Friederike Ehrhart , Lovnish Thakur , Susan Coort , and Eric Weitz

Activity

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

• NoRCE: non-coding RNA sets cis enrichment tool (2021).
• A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer’s Disease Through Expert Curation of Key Protein Targets (2020).
• Integrative epigenetic profiling analysis identifies DNA methylation changes associated with chronic alcohol consumption (2015).

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Diseases ExRNA Rare Diseases

Annotations

Pathway Ontology

Alzheimer's disease pathway disease pathway

Disease Ontology

Alzheimer's disease

References

1. Possible causes of Alzheimer’s disease: amyloid fragments, free radicals, and calcium homeostasis. Hölscher C. Neurobiol Dis. 1998 Sep;5(3):129–41. PubMed Europe PMC Scholia
2. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Ivins KJ, Thornton PL, Rohn TT, Cotman CW. Neurobiol Dis. 1999 Oct;6(5):440–9. PubMed Europe PMC Scholia
3. Neurotoxicity induces cleavage of p35 to p25 by calpain. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Nature. 2000 May 18;405(6784):360–4. PubMed Europe PMC Scholia
4. Alzheimer’s disease and Abeta toxicity: from top to bottom. Small DH, Mok SS, Bornstein JC. Nat Rev Neurosci. 2001 Aug;2(8):595–8. PubMed Europe PMC Scholia
5. Alzheimer’s disease pathogenesis and therapeutic interventions. Parihar MS, Hemnani T. J Clin Neurosci. 2004 Jun;11(5):456–67. PubMed Europe PMC Scholia
6. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? Dickson DW. J Clin Invest. 2004 Jul;114(1):23–7. PubMed Europe PMC Scholia
7. Pathways towards and away from Alzheimer’s disease. Mattson MP. Nature. 2004 Aug 5;430(7000):631–9. PubMed Europe PMC Scholia
8. Induction of neuronal death by ER stress in Alzheimer’s disease. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M. J Chem Neuroanat. 2004 Sep;28(1–2):67–78. PubMed Europe PMC Scholia
9. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer’s disease. Takuma K, Yan SS, Stern DM, Yamada K. J Pharmacol Sci. 2005 Mar;97(3):312–6. PubMed Europe PMC Scholia
10. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. Gandy S. J Clin Invest. 2005 May;115(5):1121–9. PubMed Europe PMC Scholia
11. Tau phosphorylation and aggregation in Alzheimer’s disease pathology. Avila J. FEBS Lett. 2006 May 22;580(12):2922–7. PubMed Europe PMC Scholia
12. Mitochondrial dysfunction in sporadic and genetic Alzheimer’s disease. Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Müller WE. Exp Gerontol. 2006 Jul;41(7):668–73. PubMed Europe PMC Scholia
13. Distinct destructive signal pathways of neuronal death in Alzheimer’s disease. Shen Y, He P, Zhong Z, McAllister C, Lindholm K. Trends Mol Med. 2006 Dec;12(12):574–9. PubMed Europe PMC Scholia
14. Presenilin-mediated signal transduction. Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A. Physiol Behav. 2007 Sep 10;92(1–2):93–7. PubMed Europe PMC Scholia
15. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. Mol Cell. 2007 Jul 6;27(1):91–105. PubMed Europe PMC Scholia
16. Calcium dysregulation in Alzheimer’s disease. Bojarski L, Herms J, Kuznicki J. Neurochem Int. 2008;52(4–5):621–33. PubMed Europe PMC Scholia
17. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Hébert SS, Horré K, Nicolaï L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6415–20. PubMed Europe PMC Scholia
18. Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Bezprozvanny I, Mattson MP. Trends Neurosci. 2008 Sep;31(9):454–63. PubMed Europe PMC Scholia
19. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G. Aging Cell. 2008 Dec;7(6):824–35. PubMed Europe PMC Scholia
20. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Papagiannakopoulos T, Shapiro A, Kosik KS. Cancer Res. 2008 Oct 1;68(19):8164–72. PubMed Europe PMC Scholia
21. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P, et al. Lab Invest. 2010 Feb;90(2):144–55. PubMed Europe PMC Scholia
22. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, et al. Stem Cells Dev. 2011 Feb;20(2):259–67. PubMed Europe PMC Scholia
23. miR-375 inhibits differentiation of neurites by lowering HuD levels. Abdelmohsen K, Hutchison ER, Lee EK, Kuwano Y, Kim MM, Masuda K, et al. Mol Cell Biol. 2010 Sep;30(17):4197–210. PubMed Europe PMC Scholia
24. Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, Paroni G, et al. J Biol Chem. 2011 Feb 4;286(5):4027–42. PubMed Europe PMC Scholia
25. MicroRNAs in Alzheimer’s disease. Delay C, Mandemakers W, Hébert SS. Neurobiol Dis. 2012 May;46(2):285–90. PubMed Europe PMC Scholia
26. Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas. Chan XHD, Nama S, Gopal F, Rizk P, Ramasamy S, Sundaram G, et al. Cell Rep. 2012 Sep 27;2(3):591–602. PubMed Europe PMC Scholia
27. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, et al. Cancer Chemother Pharmacol. 2013 May;71(5):1159–71. PubMed Europe PMC Scholia
28. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, et al. PLoS One. 2014 May 5;9(5):e94839. PubMed Europe PMC Scholia
29. RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage. Piras S, Furfaro AL, Domenicotti C, Traverso N, Marinari UM, Pronzato MA, et al. Oxid Med Cell Longev. 2016;2016:9348651. PubMed Europe PMC Scholia
30. Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma. Vallée A, Lecarpentier Y. Front Neurosci. 2016 Oct 19;10:459. PubMed Europe PMC Scholia
31. Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses. Wasser CR, Herz J. J Biol Chem. 2017 Jan 27;292(4):1330–8. PubMed Europe PMC Scholia
32. ApoE, ApoE Receptors, and the Synapse in Alzheimer’s Disease. Lane-Donovan C, Herz J. Trends Endocrinol Metab. 2017 Apr;28(4):273–84. PubMed Europe PMC Scholia
33. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer’s disease. Vargas LM, Cerpa W, Muñoz FJ, Zanlungo S, Alvarez AR. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1148–59. PubMed Europe PMC Scholia
34. Dysregulation of Intracellular Calcium Signaling in Alzheimer’s Disease. Popugaeva E, Pchitskaya E, Bezprozvanny I. Antioxid Redox Signal. 2018 Oct 20;29(12):1176–88. PubMed Europe PMC Scholia
35. Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1. Strickland MR, Holtzman DM. J Clin Invest. 2019 Mar 1;129(3):969–71. PubMed Europe PMC Scholia
36. Wnt Signaling Deregulation in the Aging and Alzheimer’s Brain. Palomer E, Buechler J, Salinas PC. Front Cell Neurosci. 2019 May 22;13:227. PubMed Europe PMC Scholia
37. Role of GPCR signaling and calcium dysregulation in Alzheimer’s disease. Sushma, Mondal AC. Mol Cell Neurosci. 2019 Dec;101:103414. PubMed Europe PMC Scholia